These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27121297)

  • 1. Pain tolerance predicts human social network size.
    Johnson KV; Dunbar RI
    Sci Rep; 2016 Apr; 6():25267. PubMed ID: 27121297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social Laughter Triggers Endogenous Opioid Release in Humans.
    Manninen S; Tuominen L; Dunbar RI; Karjalainen T; Hirvonen J; Arponen E; Hari R; Jääskeläinen IP; Sams M; Nummenmaa L
    J Neurosci; 2017 Jun; 37(25):6125-6131. PubMed ID: 28536272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
    Hagelberg N; Aalto S; Tuominen L; Pesonen U; Någren K; Hietala J; Scheinin H; Pertovaara A; Martikainen IK
    Neurosci Lett; 2012 Jul; 521(1):11-4. PubMed ID: 22622175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social touch modulates endogenous μ-opioid system activity in humans.
    Nummenmaa L; Tuominen L; Dunbar R; Hirvonen J; Manninen S; Arponen E; Machin A; Hari R; Jääskeläinen IP; Sams M
    Neuroimage; 2016 Sep; 138():242-247. PubMed ID: 27238727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opiates and behavior: 2014.
    Bodnar RJ
    Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J
    Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mu-opioid receptor mRNA expression in identified hypothalamic neurons.
    Zheng SX; Bosch MA; Rønnekleiv OK
    J Comp Neurol; 2005 Jul; 487(3):332-44. PubMed ID: 15892097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple opioid receptor systems in brain and spinal cord: Part I.
    Yaksh TL
    Eur J Anaesthesiol; 1984 Jun; 1(2):171-99. PubMed ID: 6152613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide VF-associated satiety involves mu and kappa but not delta subtypes of opioid receptors in chicks.
    Cline MA; Sliwa LN
    Neurosci Lett; 2009 May; 455(3):195-8. PubMed ID: 19429120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
    Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
    Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional mu opioid receptor regulation of sensory and affective dimensions of pain.
    Zubieta JK; Smith YR; Bueller JA; Xu Y; Kilbourn MR; Jewett DM; Meyer CR; Koeppe RA; Stohler CS
    Science; 2001 Jul; 293(5528):311-5. PubMed ID: 11452128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.
    Pellissier LP; Gandía J; Laboute T; Becker JAJ; Le Merrer J
    Br J Pharmacol; 2018 Jul; 175(14):2750-2769. PubMed ID: 28369738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse.
    Contet C; Matifas A; Kieffer BL
    Eur J Pharmacol; 2004 May; 492(2-3):131-6. PubMed ID: 15178356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xylazine induced central antinociception mediated by endogenous opioids and μ-opioid receptor, but not δ-or κ-opioid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Brain Res; 2013 Apr; 1506():58-63. PubMed ID: 23485547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of hypothalamic beta-endorphin neurons to mu-opioid receptor activation after chronic morphine.
    Zhang G; Lagrange AH; Rønnekleiv OK; Kelly MJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):551-8. PubMed ID: 8613967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
    Ibrahim MM; Porreca F; Lai J; Albrecht PJ; Rice FL; Khodorova A; Davar G; Makriyannis A; Vanderah TW; Mata HP; Malan TP
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3093-8. PubMed ID: 15705714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.